Back to Agenda
Part II - Presentations
Session Chair(s)
Marianne Lunzer, DrMed
Assessor, Dept of Clinical Trials, Federal Office for Safety in Health Care, AGES, Austria
Noemie Manent, PHARMD
TDA-CTT Change Management Lead, European Medicines Agency, Netherlands
Speaker(s)
Scott Feiner
Senior Manager, Trial Disclosure, AbbVie, United States
Practical Insights of Transitioning Clinical Trials From Industry Sponsor Perspective
Leonard van den Berg
, University Medical Center Utrecht (UMC) , Netherlands
Practical Insights of Transitioning Clinical Trials From Academia Sponsor Perspective
Have an account?
